Uncategorized
Ocular Therapeutix™ Reports Changes to Board of Directors
BEDFORD, Mass--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt;/agt;--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced the nomination of Seung Suh (Stanley) Hong, Ph.D. to the Board of Directors of the Company. “We are pleased to have the opportunity for Dr. Hong to join our Board of Directors. His vast experiences in the biopharmaceutical industry will bring significant strateg